Opioid-Induced Adrenal Insufficiency
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Abstract One in 10 Americans experience chronic pain. Although opioids do play a role in the management of pain, long‐term opioid use may lead to adverse effects. Endocrine‐related adverse effects have been described but remain poorly recognized. Opioid‐induced adrenal insufficiency occurs because of suppression of hypothalamic‐pituitary‐adrenal communication and may be challenging to diagnose but has been reported in 9% to 29% of patients receiving long‐term opiate therapy. Little data exist to guide case detection and patient management. Treatment includes cessation of opiates (the inciting factor) if possible and glucocorticoid replacement.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bornstein, S. R., Allolio, B., Arlt, W., Barthel, A., Don-Wauchope, A., Hammer, G. D., Husebye, E. S., Merke, D. P., Murad, M. H., Stratakis, C. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1710 · Cited by 1,769 · cited 3×
“Alternatively, new oral formulations using delayed and sustained-release multiparticulate tablets (Chronocort, Diurnal Group PLC) or immediate release with a sustained-release core (Plenadren, Shire) to better resemble a physiologic profile have been developed but are currently under study.(31) It is worth noting that…”
BackgroundInfluentialEstimates of Pain Prevalence and Severity in Adults: United States, 2012
Nahin, R. L. (2015) · The Journal of Pain · doi:10.1016/j.jpain.2015.05.002 · Cited by 918 · cited 1×
“Endogenous glucocorticoid production is estimated to be between 5 and 10 mg/m.(2,27) Hydrocortisone doses ranging from 15 to 25 mg/d, given in divideddoses 2 to 3 times a daywith themajority given on waking (50%-66%) are typically recommended.”
BackgroundEndocrine consequences of long-term intrathecal administration of opioids
Abs, R., Verhelst, J., Maeyaert, J., Van Buyten, J.-P., Opsomer, F., Adriaensen, H., Verlooy, J., Van Havenbergh, T., Smet, M., & Van Acker, K. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6615 · Cited by 491
Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 1×
“Alternative glucocorticoid preparations with a longer half-life are available (prednisone, prednisolone, and dexamethasone) andmay improve compliance but aremore likely to be associated with excess glucocorticoid effects and greater suppression of endogenous cortisol release.(28) Adequacy of replacement is based on sy…”
BackgroundOspina, N. S., Al Nofal, A., Bancos, I., Javed, A., Benkhadra, K., Kapoor, E., Lteif, A. N., Natt, N., & Murad, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1700 · Cited by 247
Self-citationAlkatib, A. A., Cosma, M., Elamin, M. B., Erickson, D., Swiglo, B. A., Erwin, P. J., & Montori, V. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0672 · Cited by 147
Impaired circadian rhythmicity of β-lipotrophin, β-endorphin and ACTH in heroin addicts
Facchinetti, F., Grasso, A., Petraglia, F., Parrini, D., Volpe, A., & Genazzani, A. R. (1984) · Acta Endocrinologica · doi:10.1530/acta.0.1050149 · Cited by 61 · cited 1×
“The results of most human studies (Table 1) suggest that long-term administration of opioids (oral, intravenous, or intrathecal) leads to suppression of the HPA axis.(11,12,20) One study, however, reported a significant increased corticotropin response to CRH stimulation in patients treated with long-term opioid thera…”
ResultAdrenal insufficiency in patients on long-term opioid analgesia
Gibb, F. W., Stewart, A., Walker, B. R., & Strachan, M. W. J. (2016) · Clinical Endocrinology · doi:10.1111/cen.13125 · Cited by 52 · cited 2×
“In opposition, a study involving 48 individuals with noncancer-associated pain receiving long-term opioid therapy (median MEDD, 68 mg) in whommorning cortisol concentrations were grouped into tertiles, lower basal cortisol levels were associated with female sex, increased body mass index, and younger age.(17)”
BackgroundSchimke, K.-E., Greminger, P., & Brändle, M. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1202851 · Cited by 36
Nenke, M. A., Haylock, C. L., Rankin, W., Inder, W. J., Gagliardi, L., Eldridge, C., Rolan, P., & Torpy, D. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.03.015 · Cited by 32 · cited 1×
“test.(23) More recently, 12% of patients (3 of 25) receiving different opioids with a median daily opioid dose of 68 mg had negative findings on a corticotropin stimulation test.”
BackgroundOpioid endocrinopathy: a clinical problem in patients with cancer pain
MERDIN, A., MERDIN, F. A., GÜNDÜZ, Ş., BOZCUK, H., & COŞKUN, H. Ş. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3156 · Cited by 32 · cited 1×
“Among those with chronic cancer pain receiving 20mg ormore of MEDDs for 1month or longer, no associationwas foundwithMEDD or patient sex and corticotropin or cortisol concentration.(18) In opposition, a study involving 48 individuals with noncancer-associated pain receiving long-term opioid therapy (median MEDD, 68 mg…”
Background
Cited by
Opioids and their endocrine effects: a systematic review and meta-analysis
de Vries, F., Bruin, M., Lobatto, D. J., Dekkers, O. M., Schoones, J. W., van Furth, W. R., Pereira, A. M., Karavitaki, N., Biermasz, N. R., & Zamanipoor Najafabadi, A. H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz022 · Cited by 139
Glintborg, D., Vaegter, H. B., Christensen, L. L., Bendix, E., Graven-Nielsen, T., Andersen, P. G., & Andersen, M. (2020) · European Journal of Endocrinology · doi:10.1530/eje-19-0979 · Cited by 32
“The 76 prevalence of insufficient adrenal response is estimated to range between 9-29% in men and women treated 77 with long term opioids (1, 12).”
BackgroundInfluentialPerioperative evaluation and management of patients on glucocorticoids
Chen Cardenas, S. M., Santhanam, P., Morris-Wiseman, L., Salvatori, R., & Hamrahian, A. H. (2022) · Journal of the Endocrine Society · doi:10.1210/jendso/bvac185 · Cited by 31
Opioids and pituitary function: expert opinion
Gadelha, M. R., Karavitaki, N., Fudin, J., Bettinger, J. J., Raff, H., & Ben-Shlomo, A. (2022) · Pituitary · doi:10.1007/s11102-021-01202-y · Cited by 27
Clinical presentation and outcomes of opioid-induced adrenal insufficiency
Li, T., Donegan, D., Hooten, W. M., & Bancos, I. (2020) · Endocrine Practice · doi:10.4158/ep-2020-0297 · Cited by 27
Self-citation
Metadata
- Authors
- Donegan, D., & Bancos, I.
- Venue
- Mayo Clinic Proceedings
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 93
- Issue
- 7
- Pages
- 937-944
- ISSN
- 0025-6196 (ISSN-L)
- OpenAlex
- W2883001962
- Cited by
- 78
- References
- 12
- FWCI
- 6.82
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.